Studies in the Area of Breast Cancer Reported from Johns Hopkins University School of Medicine (Entinostat, Nivolumab and Ipilimumab for Women With Advanced Her2-negative Breast Cancer: a Phase Ib Trial)

Press/Media

Period12 Mar 2024

Media coverage

1

Media coverage

  • TitleStudies in the Area of Breast Cancer Reported from Johns Hopkins University School of Medicine (Entinostat, Nivolumab and Ipilimumab for Women With Advanced Her2-negative Breast Cancer: a Phase Ib Trial)
    Media name/outletNewsRx Women's Health Daily
    Country/TerritoryUnited States
    Date12/03/24
    PersonsRoisin Connolly